---
title: "Roth MKM Reaffirms Their Buy Rating on BioAge Labs, Inc. (BIOA)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294546673.md"
description: "Roth MKM analyst Adam Walsh reaffirmed a Buy rating on BioAge Labs (BIOA) with a $25 price target. Additionally, Jefferies maintained its Buy rating on the stock, setting a price target of $21.00."
datetime: "2026-07-31T18:55:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294546673.md)
  - [en](https://longbridge.com/en/news/294546673.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294546673.md)
generator: "portal-rs"
---

# Roth MKM Reaffirms Their Buy Rating on BioAge Labs, Inc. (BIOA)

In a report released today, Adam Walsh from Roth MKM maintained a Buy rating on BioAge Labs, Inc., with a price target of $25.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Walsh is a 3-star analyst with an average return of 4.4% and a 43.20% success rate. Walsh covers the Healthcare sector, focusing on stocks such as Equillium, Insmed, and Arcturus Therapeutics.

In a report released today, Jefferies also maintained a Buy rating on the stock with a $21.00 price target.

### Related Stocks

- [BIOA.US](https://longbridge.com/en/quote/BIOA.US.md)
- [EQ.US](https://longbridge.com/en/quote/EQ.US.md)
- [INSM.US](https://longbridge.com/en/quote/INSM.US.md)
- [ARCT.US](https://longbridge.com/en/quote/ARCT.US.md)
- [JEF.US](https://longbridge.com/en/quote/JEF.US.md)

## Related News & Research

- [354,395 Shares in BioAge Labs, Inc. $BIOA Bought by Walleye Capital LLC](https://longbridge.com/en/news/295998866.md)
- [BioAge Therapeutics: Buy Rating Maintained Despite Cut in Price Target to $21 on Refined ASCVD and Ocular Program Assumptions](https://longbridge.com/en/news/294547996.md)
- [DEC-MAR CORN SPREAD (ZCZ26-ZCH27) - WALSH PURE SPREADER](https://longbridge.com/en/news/296539414.md)
- [Analyst Justin Walsh Reiterates Buy on NeuroOne, Maintains $8 Target on Partner-Driven RF Ablation Growth and Pipeline Upside](https://longbridge.com/en/news/296260661.md)
- [Denison Mines (DNN) Receives a Buy from Roth MKM](https://longbridge.com/en/news/296056406.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**